<DOC>
	<DOCNO>NCT02468453</DOCNO>
	<brief_summary>This multi-center , multi-cohort , prospective , open-label study VELOS treatment vascular skin disorder . The plan enroll 60 subject 3 center US worldwide . The purpose collect data use VELOS .</brief_summary>
	<brief_title>VELOS Treatment Vascular Lesions Skin Rejuvenation</brief_title>
	<detailed_description>The primary objective trial collect data use VELOS clinical practice wide range treatment parameter variability include RF energy , laser fluence , laser pulse duration treat vascular disorder . This conduct document physician select treatment parameter , well subject ' clinical clearing response , perception improvement sensation , study treatment post-treatment ( ) follow-up visit . Optional exploratory objective : Collection safety efficacy data Velos DCD cool Velos contact cooling . The investigator may opt include study noninvasive measurement erythema , melanin texture ( may perform eg . Chromameter , Mexameter 3D imaging ) , measurement linear vessel diameter lesion size .</detailed_description>
	<criteria>1 . Subject healthy Male Female least 18 year age 2 . Subject vascular ( blood vessel ) skin disorder erythematous scar erythematous stria wish improve skin laxity skin firmness . In special case nonerythematous scar nonerythematous stria may allow well . 3 . Fitzpatrick Skin Type I VI 4 . Subject must able read , understand sign Informed Consent Form 5 . Subject must willing able adhere treatment followup schedule posttreatment care instruction 6 . Subject must willing limited sun exposure duration study , include followup period 7 . Subject willing photograph and/or video take treated area use , deidentified , evaluation may use , deidentified , presentation and/or publication 8 . For female candidate subject must postmenopausal , surgically sterilize , use medically acceptable form birth control entire course study . 1 . Subject pregnant planning become pregnant study duration . Pregnancy assess question screening . 2 . Subject active electrical implant anywhere body , pacemaker internal defibrillator . 3 . Subject implant treat area ( metal plate screw ) inject chemical substance , include Botox collagen injection ( face area treat ) . 4 . Subject know collagen ( connective tissue ) disorder , vascular disease , scleroderma autoimmune disease ( i.e . rheumatoid arthritis , lupus ) . 5 . Subject history disease stimulate heat sun exposure , recurrent Herpes Simplex treat area , unless treatment conduct follow prophylactic regimen . 6 . Subject history immunosuppression/immune deficiency disorder ( include HIV infection AIDS ) currently use immunosuppressive medication . 7 . Having undergoing form treatment active cancer , history skin cancer cancer area treat , include actinic keratosis , presence malignant premalignant pigment lesion . 8 . Subject suffer significant concurrent illness , cardiac disorder , diabetes ( type I II ) , pertinent neurological disorder . 9 . Subject infection suffer current history significant skin condition treat area inflammatory skin condition , include , limited : photodermatoses , active acne , excessive skin dryness , psoriasis , eczema , rash , rosacea ( particularly severe open wound stage ) , varicella scar , open laceration abrasion active cold sore herpes sore prior treatment ( duration resolution per Investigator 's discretion ) treatment course . 10 . Having know anticoagulative thromboembolic condition take anticoagulation medication one week prior treatment course ( allow inclusion , temporary cessation use per subject 's physician discretion ) . 11 . Use nonsteroidal antiinflammatory drug ( NSAIDS , e.g. , ibuprofencontaining agent ) one week treatment session . 12 . Subject history pigmentary disorder , particularly tendency hyper hypopigmentation . 13 . Subject history keloid scar abnormal wound healing . 14 . Subject know photosensitivity study laser wavelength , history ingesting medication know induce photosensitivity , history seizure disorder due light . 15 . Subject undergone surgical , lightbased therapy RF procedures treatment area within 3 month treatment study . 16 . Having undergone surgery treat area within 3 month treatment ( skin heal completely ) study . 17 . Subject undergone facial dermabrasion chemical peel treatment within 3 month treatment study ( face treat ) . 18 . Having receive Botox/collagen/fat injection method augmentation inject implanted material treat area within 9 month treatment study ( face treat ) . 19 . Subject undergone resurfacing procedure , face lift eyelid surgery within year treatment study ( face treat ) . 20 . Subject tattoo permanent makeup treat area . 21 . Subject systemically used retinoids , antioxidant medical grade skin nourish supplement within 2 month treatment study . 22 . Excessively tanned area treat unable/unlikely refrain tan study . 23 . Participation study another device drug within three month prior enrollment study . 24 . As per Investigator 's discretion , physical mental condition might make unsafe subject participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>velos</keyword>
	<keyword>Vascular</keyword>
	<keyword>Rejuvenation</keyword>
</DOC>